Transcriptional network analysis implicates altered hepatic immune function in NASH development and resolution (original) (raw)

• Haas, J. T., Francque, S. & Staels, B. Pathophysiology and mechanisms of nonalcoholic fatty liver disease. Annu. Rev. Physiol. 78, 181–205 (2016).
  Article CAS Google Scholar
• Luyckx, F. H., Lefebvre, P. J. & Scheen, A. J. Non-alcoholic steatohepatitis: association with obesity and insulin resistance, and influence of weight loss. Diabetes Metab. 26, 98–106 (2000).
  CAS PubMed Google Scholar
• Brunt, E. M. Pathology of nonalcoholic fatty liver disease. Nat. Rev. Gastroenterol. Hepatol. 7, 195–203 (2010).
  Article Google Scholar
• Brunt, E. M. et al. Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings. Hepatology 53, 810–820 (2011).
  Article CAS Google Scholar
• Bedossa, P. et al. Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients. Hepatology 56, 1751–1759 (2012).
  Article Google Scholar
• Hirsova, P. & Gores, G. J. Ballooned hepatocytes, undead cells, sonic hedgehog, and vitamin E: therapeutic implications for nonalcoholic steatohepatitis. Hepatology 61, 15–17 (2015).
  Article Google Scholar
• Vonghia, L., Michielsen, P. & Francque, S. Immunological mechanisms in the pathophysiology of non-alcoholic steatohepatitis. Int. J. Mol. Sci. 14, 19867–19890 (2013).
  Article Google Scholar
• Liaskou, E. et al. Monocyte subsets in human liver disease show distinct phenotypic and functional characteristics. Hepatology 57, 385–398 (2013).
  Article CAS Google Scholar
• Rau, M. et al. Progression from nonalcoholic fatty liver to nonalcoholic steatohepatitis is marked by a higher frequency of Th17 cells in the liver and an increased Th17/resting regulatory T cell ratio in peripheral blood and in the liver. J. Immunol. 196, 97–105 (2016).
  Article CAS Google Scholar
• Wolf, M. J. et al. Metabolic activation of intrahepatic CD8+ T cells and NKT cells causes nonalcoholic steatohepatitis and liver cancer via cross-talk with hepatocytes. Cancer Cell 26, 549–564 (2014).
  Article CAS Google Scholar
• Kleiner, D. E. & Bedossa, P. Liver histology and clinical trials for nonalcoholic steatohepatitis-perspectives from 2 pathologists. Gastroenterology 149, 1305–1308 (2015).
  Article Google Scholar
• Ryaboshapkina, M. & Hammar, M. Human hepatic gene expression signature of non-alcoholic fatty liver disease progression, a meta-analysis. Sci. Rep. 7, 12361 (2017).
  Article Google Scholar
• Moylan, C. A. et al. Hepatic gene expression profiles differentiate presymptomatic patients with mild versus severe nonalcoholic fatty liver disease. Hepatology 59, 471–482 (2014).
  Article CAS Google Scholar
• Vilar-Gomez, E. et al. Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis. Gastroenterology 149, 367–378 e365 (2015).
  Article Google Scholar
• Lassailly, G. et al. Bariatric surgery reduces features of nonalcoholic steatohepatitis in morbidly obese patients. Gastroenterology 149, 379–388 (2015).
  Article Google Scholar
• Lefebvre, P. et al. Interspecies NASH disease activity whole-genome profiling identifies a fibrogenic role of PPARalpha-regulated dermatopontin. JCI Insight 2, e92264 (2017).
  Article Google Scholar
• Langfelder, P. & Horvath, S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics 9, 559 (2008).
  Article Google Scholar
• Vonghia, L. et al. CD4+ROR gamma t++ and tregs in a mouse model of diet-induced nonalcoholic steatohepatitis. Mediators Inflamm. 2015, 239623 (2015).
  Article Google Scholar
• Bhattacharjee, J. et al. Hepatic natural killer T-cell and CD8+ T-cell signatures in mice with nonalcoholic steatohepatitis. Hepatol. Commun. 1, 299–310 (2017).
  Article CAS Google Scholar
• Sutti, S. et al. Adaptive immune responses triggered by oxidative stress contribute to hepatic inflammation in NASH. Hepatology 59, 886–897 (2014).
  Article CAS Google Scholar
• Clapper, J. R. et al. Diet-induced mouse model of fatty liver disease and nonalcoholic steatohepatitis reflecting clinical disease progression and methods of assessment. Am. J. Physiol. Gastrointest. Liver Physiol. 305, G483–G495 (2013).
  Article CAS Google Scholar
• Asgharpour, A. et al. A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer. J. Hepatol. 65, 579–588 (2016).
  Article CAS Google Scholar
• Jensen, T. et al. Fructose and sugar: a major mediator of non-alcoholic fatty liver disease. J. Hepatol. 68, 1063–1075 (2018).
  Article CAS Google Scholar
• Ioannou, G. N. The role of cholesterol in the pathogenesis of NASH. Trends Endocrinol. Metab. 27, 84–95 (2016).
  Article CAS Google Scholar
• Bottini, N. & Peterson, E. J. Tyrosine phosphatase PTPN22: multifunctional regulator of immune signaling, development, and disease. Annu. Rev. Immunol. 32, 83–119 (2014).
  Article CAS Google Scholar
• Froylich, D. et al. Effect of Roux-en-Y gastric bypass and sleeve gastrectomy on nonalcoholic fatty liver disease: a comparative study. Surg. Obes. Relat. Dis. 12, 127–131 (2016).
  Article Google Scholar
• Patouraux, S. et al. CD44 is a key player in non-alcoholic steatohepatitis. J. Hepatol. 67, 328–338 (2017).
  Article CAS Google Scholar
• Zhang, X. et al. CXCL10 plays a key role as an inflammatory mediator and a non-invasive biomarker of non-alcoholic steatohepatitis. J. Hepatol. 61, 1365–1375 (2014).
  Article CAS Google Scholar
• Tilg, H., Moschen, A. R. & Roden, M. NAFLD and diabetes mellitus. Nat. Rev. Gastroenterol. Hepatol. 14, 32–42 (2017).
  Article CAS Google Scholar
• Syn, W. K. et al. Accumulation of natural killer T cells in progressive nonalcoholic fatty liver disease. Hepatology 51, 1998–2007 (2010).
  Article CAS Google Scholar
• Miura, K., Yang, L., van Rooijen, N., Ohnishi, H. & Seki, E. Hepatic recruitment of macrophages promotes nonalcoholic steatohepatitis through CCR2. Am. J. Physiol. Gastrointest. Liver Physiol. 302, G1310–G1321 (2012).
  Article CAS Google Scholar
• Durai, V. & Murphy, K. M. Functions of murine dendritic cells. Immunity 45, 719–736 (2016).
  Article CAS Google Scholar
• Vu Manh, T. P., Bertho, N., Hosmalin, A., Schwartz-Cornil, I. & Dalod, M. Investigating evolutionary conservation of dendritic cell subset identity and functions. Front. Immunol. 6, 260 (2015).
  Google Scholar
• Henning, J. R. et al. Dendritic cells limit fibroinflammatory injury in nonalcoholic steatohepatitis in mice. Hepatology 58, 589–602 (2013).
  Article CAS Google Scholar
• Worbs, T., Hammerschmidt, S. I. & Forster, R. Dendritic cell migration in health and disease. Nat. Rev. Immunol. 17, 30–48 (2017).
  Article CAS Google Scholar
• Kelly, A. et al. CD141(+) myeloid dendritic cells are enriched in healthy human liver. J. Hepatol. 60, 135–142 (2014).
  Article CAS Google Scholar
• Doganay, L. et al. HLA DQB1 alleles are related with nonalcoholic fatty liver disease. Mol. Biol. Rep. 41, 7937–7943 (2014).
  Article CAS Google Scholar
• Nishimura, S. et al. CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat. Med. 15, 914–920 (2009).
  Article CAS Google Scholar
• Wieser, V. et al. Adipose type I interferon signalling protects against metabolic dysfunction. Gut 67, 157–165 (2018).
  Article CAS Google Scholar
• Ghazarian, M. et al. Type I interferon responses drive intrahepatic T cells to promote metabolic syndrome. Sci. Immunol. 2, eaai7616 (2017).
  Article Google Scholar
• Luo, J. L., Kamata, H. & Karin, M. IKK/NF-kappaB signaling: balancing life and death—a new approach to cancer therapy. J. Clin. Invest. 115, 2625–2632 (2005).
  Article CAS Google Scholar
• du Plessis, J. et al. Association of adipose tissue inflammation with histologic severity of nonalcoholic fatty liver disease. Gastroenterology 149, 635–648 e614 (2015).
  Article Google Scholar
• Bijnen, M. et al. Adipose tissue macrophages induce hepatic neutrophil recruitment and macrophage accumulation in mice. Gut 67, 1317–1327 (2018).
  Article CAS Google Scholar
• Francque, S. et al. PPARalpha gene expression correlates with severity and histological treatment response in patients with non-alcoholic steatohepatitis. J. Hepatol. 63, 164–173 (2015).
  Article CAS Google Scholar
• Matthews, D. R. et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412–419 (1985).
  Article CAS Google Scholar
• Verrijken, A. et al. A gene variant of PNPLA3, but not of APOC3, is associated with histological parameters of NAFLD in an obese population. Obesity (Silver Spring) 21, 2138–2145 (2013).
  Article CAS Google Scholar
• Kleiner, D. E. et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41, 1313–1321 (2005).
  Article Google Scholar
• Rubtsov, Y. P. et al. Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity 28, 546–558 (2008).
  Article CAS Google Scholar
• Pawlak, M. et al. The transrepressive activity of peroxisome proliferator-activated receptor alpha is necessary and sufficient to prevent liver fibrosis. Hepatology 60, 1593–1606 (2014).
  Article CAS Google Scholar
• Irizarry, R. A. et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4, 249–264 (2003).
  Article Google Scholar
• Leek, J. T. & Storey, J. D. Capturing heterogeneity in gene expression studies by surrogate variable analysis. PLoS Genet. 3, 1724–1735 (2007).
  Article CAS Google Scholar
• Smyth, G. K., Michaud, J. & Scott, H. S. Use of within-array replicate spots for assessing differential expression in microarray experiments. Bioinformatics 21, 2067–2075 (2005).
  Article CAS Google Scholar
• Goeman, J. J. & Buhlmann, P. Analyzing gene expression data in terms of gene sets: methodological issues. Bioinformatics 23, 980–987 (2007).
  Article CAS Google Scholar